About this trial

This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.

Eligibility criteria

Qualifiers

Adults aged 19 years or older.

Diagnosed with hypertension.

Regular use of antihypertensive medication for at least two years.

Access to a home blood pressure monitor.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Healthscan App

Treatment groups

4,188 Participants
are divided into 1 treatment group

Locations

2
Korea Univeristy Guro Hospital08308, Seoul South Korea
Korea University Anam Hospital02841, Seoul South Korea

Sponsors and collaborators

Korea University Anam Hospital

Lead sponsor

Korean Society of Hypertension

Collaborator